We found that breast cancer with high GALNT1 expression in AYA patients significantly enriched angiogenesis, EMT, and protein secretion gene sets, consistently in both the METABRIC and GSE96058 cohorts (Figure 5). Here, GALNT1 is linked to breast cancer.